129 related articles for article (PubMed ID: 29278897)
1. Reliability of the Apathy Evaluation Scale in Myotonic Dystrophy Type 1.
Gallais B; Gagnon C; Côté I; Forgues G; Laberge L
J Neuromuscul Dis; 2018; 5(1):39-46. PubMed ID: 29278897
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and correlates of apathy in myotonic dystrophy type 1.
Gallais B; Montreuil M; Gargiulo M; Eymard B; Gagnon C; Laberge L
BMC Neurol; 2015 Aug; 15():148. PubMed ID: 26296336
[TBL] [Abstract][Full Text] [Related]
3. Apathy in multiple sclerosis: a validation study of the apathy evaluation scale.
Raimo S; Trojano L; Spitaleri D; Petretta V; Grossi D; Santangelo G
J Neurol Sci; 2014 Dec; 347(1-2):295-300. PubMed ID: 25455303
[TBL] [Abstract][Full Text] [Related]
4. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).
DiPaolo G; Jimenez-Moreno C; Nikolenko N; Atalaia A; Monckton DG; Guglieri M; Lochmüller H
J Neurol; 2017 Apr; 264(4):701-708. PubMed ID: 28168524
[TBL] [Abstract][Full Text] [Related]
5. Reliability and validity of the self-report version of the apathy evaluation scale in first-episode Psychosis: Concordance with the clinical version at baseline and 12 months follow-up.
Faerden A; Lyngstad SH; Simonsen C; Ringen PA; Papsuev O; Dieset I; Andreassen OA; Agartz I; Marder SR; Melle I
Psychiatry Res; 2018 Sep; 267():140-147. PubMed ID: 29906681
[TBL] [Abstract][Full Text] [Related]
6. Translation, reliability, and validity of the Norwegian version of the ABILHAND-NMD and the ACTIVLIM for Myotonic Dystrophy type 1.
Fossmo HL; Ørstavik K; Frich JC; Robinson HS
Disabil Rehabil; 2024 Jun; 46(12):2699-2707. PubMed ID: 37438996
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Italian version of the Apathy Evaluation Scale (AES-I) in institutionalized geriatric patients.
Borgi M; Caccamo F; Giuliani A; Piergentili A; Sessa S; Reda E; Alleva E; Cirulli F; Miraglia F
Ann Ist Super Sanita; 2016; 52(2):249-55. PubMed ID: 27364400
[TBL] [Abstract][Full Text] [Related]
8. Fatigue and daytime sleepiness rating scales in myotonic dystrophy: a study of reliability.
Laberge L; Gagnon C; Jean S; Mathieu J
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1403-5. PubMed ID: 16170085
[TBL] [Abstract][Full Text] [Related]
9. The Myotonic Dystrophy Health Index: Italian validation of a disease-specific outcome measure.
Sansone VA; Lizio A; Greco L; Gragnano G; Zanolini A; Gualandris M; Iatomasi M; Heatwole C
Neuromuscul Disord; 2017 Nov; 27(11):1047-1053. PubMed ID: 28890289
[TBL] [Abstract][Full Text] [Related]
10. Measurement of participation in myotonic dystrophy: reliability of the LIFE-H.
Gagnon C; Mathieu J; Noreau L
Neuromuscul Disord; 2006 Apr; 16(4):262-8. PubMed ID: 16545567
[TBL] [Abstract][Full Text] [Related]
11. Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.
Van Heugten C; Meuleman S; Hellebrekers D; Kruitwagen-van Reenen E; Visser-Meily J
J Neuromuscul Dis; 2018; 5(2):205-214. PubMed ID: 29865086
[TBL] [Abstract][Full Text] [Related]
12. Myotonic Dystrophy Health Index: initial evaluation of a disease-specific outcome measure.
Heatwole C; Bode R; Johnson N; Dekdebrun J; Dilek N; Heatwole M; Hilbert JE; Luebbe E; Martens W; Mcdermott MP; Rothrock N; Thornton C; Vickrey BG; Victorson D; Moxley R
Muscle Nerve; 2014 Jun; 49(6):906-14. PubMed ID: 24142420
[TBL] [Abstract][Full Text] [Related]
13. Development of a disability scale for myotonic dystrophy type 1.
Contardi S; Pizza F; Falzone F; D'Alessandro R; Avoni P; Di Stasi V; Montagna P; Liguori R
Acta Neurol Scand; 2012 Jun; 125(6):431-8. PubMed ID: 21902674
[TBL] [Abstract][Full Text] [Related]
14. Clinical Outcome Evaluations and CBT Response Prediction in Myotonic Dystrophy.
van As D; Okkersen K; Bassez G; Schoser B; Lochmüller H; Glennon JC; Knoop H; van Engelen BGM; 't Hoen PAC;
J Neuromuscul Dis; 2021; 8(6):1031-1046. PubMed ID: 34250945
[TBL] [Abstract][Full Text] [Related]
15. Apathy and hypersomnia are common features of myotonic dystrophy.
Rubinsztein JS; Rubinsztein DC; Goodburn S; Holland AJ
J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):510-5. PubMed ID: 9576545
[TBL] [Abstract][Full Text] [Related]
16. Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer's disease.
Hsieh CJ; Chu H; Cheng JJ; Shen WW; Lin CC
Psychiatry Clin Neurosci; 2012 Apr; 66(3):227-34. PubMed ID: 22443245
[TBL] [Abstract][Full Text] [Related]
17. Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ).
Hermans MC; Faber CG; De Baets MH; de Die-Smulders CE; Merkies IS
Neuromuscul Disord; 2010 May; 20(5):310-8. PubMed ID: 20363134
[TBL] [Abstract][Full Text] [Related]
18. Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients.
Symonds T; Randall JA; Campbell P
Muscle Nerve; 2017 Jul; 56(1):86-92. PubMed ID: 27862031
[TBL] [Abstract][Full Text] [Related]
19. Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia.
Martínez-Cao C; García-Álvarez L; Bobes-Bascarán T; de la Fuente-Tomás L; Fernández-Egea E; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz-Martínez PA; García-Portilla MP; Bobes J
Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(1):22-28. PubMed ID: 35256069
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for the reliability and validity of the Fatigue and Daytime Sleepiness Scale.
Gallais B; Gagnon C; Forgues G; Côté I; Laberge L
J Neurol Sci; 2017 Apr; 375():23-26. PubMed ID: 28320135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
